Clofarabine Patent Expiration
Clofarabine is Used for treating pediatric patients aged 1 to 21 years with relapsed or refractory acute lymphoblastic leukemia. It was first introduced by Genzyme Corp
Clofarabine Patents
Given below is the list of patents protecting Clofarabine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Clolar | US5661136 | 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
Jan 14, 2018
(Expired) | Genzyme |
| Clolar |
US5661136 (Pediatric) | 2-halo-2'-fluoro ARA adenosines as antinoplastic agents |
Jul 14, 2018
(Expired) | Genzyme |
Try Our Curated Drug Screens
Clofarabine Generics
Several generic applications have been filed for Clofarabine. The first generic version for Clofarabine was by Abon Pharmaceuticals Llc and was approved on May 9, 2017. And the latest generic version is by Eugia Pharma Specialities Ltd and was approved on Oct 3, 2022.
Given below is the list of companies who have filed for Clofarabine generic.
1. ABON PHARMS LLC
Abon Pharmaceuticals Llc has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Abon Pharms Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | May 9, 2017 |
2. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Feb 22, 2019 |
3. AMNEAL
Amneal Eu Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Amneal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Nov 6, 2017 |
4. DR REDDYS
Dr Reddys Laboratories Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Nov 6, 2017 |
5. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Oct 3, 2022 |
6. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Oct 31, 2018 |
7. HOSPIRA
Hospira Inc has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Dec 27, 2018 |
8. MEITHEAL
Meitheal Pharmaceuticals Inc has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Meitheal.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Oct 23, 2020 |
9. MSN
Msn Laboratories Private Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Msn.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Dec 6, 2017 |
10. MYLAN LABS LTD
Mylan Laboratories Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Mylan Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Prescription | INTRAVENOUS | AP | Nov 6, 2017 |
11. NOVAST LABS
Novast Laboratories Ltd has filed for 1 generic for Clofarabine. Given below are the details of the strengths of this generic introduced by Novast Labs.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/20ML (1MG/ML) | solution | Discontinued | INTRAVENOUS | N/A | Sep 14, 2018 |